Monthly Archives: December 2012

Targeted Medical Pharma to Present at OneMedForum Healthcare Conference

Los Angeles, December 18, 2012 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies , today announced that members of its executive team are scheduled to present at the sixth annual OneMedForum on January 8, 2013 at 3:40 p.m. PST, being held at the Sir Francis Drake Hotel in San Francisco. Management also will conduct one-on-one meetings with investors from January 7-9, 2013, concurrent with the 31st Annual J.P. Morgan Continue reading →

Study Finds Loss of Normal Nighttime Parasympathetic Activity in Veterans Suffering from Gulf War Syndrome

Los Angeles, December 12, 2012 — A scientific paper confirming the relationship between autonomic nervous system dysfunction and Gulf War Illness was published online  November 26, 2012  in the Archives of Neurology, according to Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies. The paper, “Cholinergic Autonomic Dysfunction in Veterans with Gulf War Illness,” revealed a blunting or loss of normal nighttime parasympathetic activity in veterans suffering from Gulf War Illness Continue reading →

Targeted Medical Pharma Introduces Medical Food Percura for Dietary Management of Peripheral Neuropathy

Data Shows New Oral Formulation Reduced Symptoms of Pain and Numbness Los Angeles, December  5, 2012 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies, today reported preliminary data indicating that its new amino acid-based oral formulation PERCURA™ reduced symptoms of pain and numbness related to peripheral neuropathy in an open-label pilot study.   “Preliminary study results show medical food PERCURA™ was able to reduce symptoms found in subjects suffering from Continue reading →

Targeted Medical Pharma to Present at 5th Annual LD Micro Growth Conference

Los Angeles, December 4, 2012 – Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies today announced that members of its executive team are scheduled to present and conduct one-on-one meetings at the LD Micro Growth Conference on December 6, 2012 at 3:30 p.m. Pacific Time. The conference is being held at the Luxe Sunset Bel Air Hotel in Los Angeles, CA. About Targeted Medical Pharma, Inc. Targeted Medical Pharma, Inc., a Continue reading →